Overexpression of PKM2 promotes mitochondrial fusion through attenuated p53 stability

Haili Wu1, Peng Yang1, Wanglai Hu2

  • 1Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Shanxi University, Taiyuan 030006, China.

Oncotarget
|November 2, 2016
PubMed

Insights

Pyruvate kinase M2 (PKM2) overexpression inhibits mitochondrial function by downregulating p53 and Drp1. This PKM2-p53-Drp1 axis offers a new therapeutic target for mitochondrial disorders.

Area of Science:

  • Cell Biology
  • Mitochondrial Biology
  • Cancer Metabolism

Background:

  • Pyruvate kinase M2 (PKM2) is known to promote the Warburg effect in cancer.
  • The impact of PKM2 on mitochondrial function remains largely unexplored.

Purpose of the Study:

  • To investigate the role of PKM2 in regulating mitochondrial function.
  • To elucidate the molecular mechanisms linking PKM2 to mitochondrial dynamics and cellular metabolism.

Main Methods:

  • Overexpression and knockdown of PKM2 in cellular models.
  • Analysis of mitochondrial morphology, ATP production, mtDNA copy number, and electron transport chain (ETC) complex expression.
  • Western blotting and co-immunoprecipitation to assess protein levels and interactions (p53, MDM2, Drp1).
  • Analysis of clinical samples to confirm PKM2-Drp1 relationship.

Main Results:

  • PKM2 overexpression led to mitochondrial fusion, decreased ATP production, elevated mtDNA copy number, and reduced ETC complex expression.
  • PKM2 overexpression suppressed p53 levels and half-life by promoting MDM2-mediated ubiquitination.
  • PKM2 directly binds to p53 and MDM2, with dimeric PKM2 showing stronger suppression of p53.
  • A negative correlation between PKM2 and Drp1 expression was observed in clinical samples.

Conclusions:

  • PKM2 inhibits mitochondrial function through the downregulation of the p53-Drp1 axis.
  • This study reveals a novel mechanism connecting PKM2 to mitochondrial dysfunction.
  • The PKM2-p53-Drp1 pathway represents a potential therapeutic target for diseases involving mitochondrial abnormalities.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K